Back to jobs

Director, GCP Quality Assurance

South San Francisco

ABOUT THE COMPANY

Marea Therapeutics is a clinical-stage biotechnology company based in South San Francisco with a growing pipeline of first-in-class therapies to address genetically validated cardioendocrine disease targets. Our therapies have the potential to serve as transformative treatment options for significant patient populations living with cardioendocrine diseases.  

The company’s lead program, MAR001, is being developed for the treatment of severe hypertriglyceridemia (sHTG), a condition characterized by very high triglyceride levels and elevated risk of acute pancreatitis. Preclinical models with MAR001 demonstrated reduction in triglycerides, remnant cholesterol and ectopic fat, and improved insulin sensitivity. MAR001 has demonstrated strong and a differentiated profile in patients and is approaching Phase 3 development. Our second clinical asset, MAR002, is a monoclonal antibody targeting excess growth hormone produced by the pituitary gland in the rare hormonal disorder, acromegaly.  MAR002 has potential to become best-in-disease and is quickly progressing into Phase 2/3 clinical development.  We also have a third asset that is swiftly advancing through research discovery, with DC nomination expected this year. 

At Marea, we believe in the power of collaboration and the importance of leading by example. We are a tight-knit team that values the contributions of every member, from interns to senior leaders. Our environment is dynamic, with each day presenting new challenges and opportunities for growth. Every role is “Hands-On”, and the successful candidate will be able to work alongside team members, regardless of level, to understand challenges and drive results.  

ABOUT THE ROLE

We are seeking a motivated Director, Good Clinical Practice (GCP) Quality Assurance to build and lead the GCP quality program supporting Marea’s clinical portfolio. The incumbent will be responsible for Marea’s GCP quality management system, the risk-based clinical audit program, and GCP inspection readiness as our programs advance to Phase 3 clinical development.

This is a hands-on, build-oriented role. The position requires a strong ability to both think strategically and execute directly, planning and conducting audits, authoring procedures, and partnering day to day with clinical study teams, as well as working well independently and in collaboration with internal and external cross-functional teams. The position reports to the Executive Director, Regulatory Affairs and will be involved in the future development and growth of the GCP Quality function. The role carries independent quality judgment and direct escalation authority for material GCP compliance matters.

KEY RESPONSIBILITIES

  • Establish, implement, and continuously mature Marea’s GCP quality management system, ensuring processes are phase-appropriate, compliant, and scalable as the clinical portfolio advances
  •  Own the risk-based GCP audit program, including the annual and study-specific audit plans; plan and personally conduct audits of investigator sites, CROs, central labs, and specialty clinical vendors, and manage the selection, workflow, and deliverable quality of contract auditors
  • Lead GCP inspection readiness across programs, including mock inspections, subject matter expert preparation, and the front-room/back-room operating model
  • Drive pre-submission GCP inspection readiness for marketing application(s), including for-cause audits of high-enrolling and high-risk investigator sites, Trial Master File completeness and traceability, and reconstruction readiness of the clinical submission dataset
  • Lead the development, review, approval, implementation, and lifecycle management of GCP SOPs and controlled documents; partner with Clinical Development and Clinical Operations to implement fit-for-purpose procedures
  •  Lead risk-based qualification and ongoing oversight of CROs and clinical vendors (e.g., central and specialty labs, EDC, IRT, eCOA, and eTMF providers), including qualification audits, quality agreements, performance monitoring, and vendor governance; serve as the sponsor Quality counterpart to CRO and vendor quality organizations
  • Oversee GCP quality events, protocol deviations, investigations, root cause analysis, CAPAs, and effectiveness verification
  • Serve as the day-to-day Quality partner to clinical study teams, embedded from protocol review through clinical study report, and provide quality review of key clinical documents including protocols, informed consent forms, monitoring plans, data management plans, TMF plans, clinical study reports, Investigator’s Brochures, and the clinical sections of regulatory submissions
  • Lead or oversee investigations of significant non-compliance, including suspected serious breaches (EU CTR Article 52), data integrity concerns, and scientific misconduct, and support notification decisions in partnership with Regulatory Affairs and Legal
  • Develop and deliver GCP training and maintain GCP training curricula and matrices for internal staff and external partners involved in clinical trials
  • Compile, trend, and report GCP quality metrics and vendor quality performance to leadership, and drive periodic quality management review
  • Monitor evolving GCP regulations, guidance, and inspection trends; interpret and translate requirements into practical, actionable guidance for study teams and company leadership

QUALIFICATIONS
  • 12+ years of pharmaceutical or biotech industry experience, with at least 8 years in GCP/Clinical Quality Assurance
  • Bachelor’s Degree in a life science, nursing, pharmacy, or related field; advanced degree preferred
  • Minimum 5 years of experience personally planning and conducting GCP audits of investigator sites, CROs, and clinical vendors
  • Demonstrated sponsor-side experience qualifying and overseeing CROs and clinical vendors, including qualification audits, quality agreements, and risk-based ongoing oversight
  • Demonstrated experience preparing for, hosting, and supporting health authority GCP inspections (FDA BIMO, EMA, MHRA); experience supporting a BLA/NDA/MAA submission strongly preferred
  • Experience supporting global late-stage, pivotal, or registrational clinical trials
  • Demonstrated experience building or maturing a GCP quality system in a small or emerging company, rather than maintaining an established one
  • Strong working knowledge of ICH E6(R3), ICH E8(R1), 21 CFR Parts 11, 50, 54, 56, and 312, EU Clinical Trials Regulation 536/2014 and CTIS, and applicable global GCP requirements
  • Experience with eTMF and electronic QMS platforms (e.g., Veeva Vault), including familiarity with 21 CFR Part 11 and EudraLex Annex 11 expectations for GCP computerized systems
  • Professional certification (RQAP-GCP, ASQ CQA, CCRA, or RAC) preferred
  • Demonstrated ability to assess compliance risk, interpret regulations and guidance, and implement practical, phase-appropriate solutions
  • Ability to collaborate and influence cross-functionally and to develop strong relationships with partners both internally and externally, while maintaining independent quality judgment
  • Ability to lead and build high functioning teams
  • Experience selecting and managing external quality resources, such as contract auditors and GCP QA consultants, including scoping, budget, and quality of deliverables
  • Strong oral and written communication skills, with the ability to translate complex regulatory requirements into clear guidance and to influence at all levels of the organization
  • Exceptional time and project management skills, with the ability to execute plans under pressure in a small, fast-paced environment with tight deadlines.
  • Comfort with ambiguity and a demonstrated hands-on approach. Ideal candidates will have late-stage development through filing experience, within a small company environment.

PAY RANGE

In compliance with applicable pay transparency laws, the expected base salary range for this position is $205,000 to $235,000 annually. This range represents the Company's good faith estimate of the salary range for this role at the date of hire and is subject to change. 

We do not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity or expression, national origin, age, disability, veteran status, marital status, or based on an individual’s status in any group or class protected by applicable federal, state, and local law. We invite applications from minorities, women, the disabled, protected veterans, and all other qualified applicants. 

Create a Job Alert

Interested in building your career at Marea Therapeutics? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Phone
Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf


Education

Select...
Select...
Select...

Select...
Select...

U.S. Standard Demographic Questions

We invite applicants to share their demographic background. If you choose to complete this survey, your responses may be used to identify areas of improvement in our hiring process.
Select...
Select...
Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Marea Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...